{"id":"https://openalex.org/W4382986119","doi":"https://doi.org/10.21873/cdp.10241","title":"An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma","display_name":"An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma","publication_year":2023,"publication_date":"2023-07-03","ids":{"openalex":"https://openalex.org/W4382986119","doi":"https://doi.org/10.21873/cdp.10241","pmid":"https://pubmed.ncbi.nlm.nih.gov/37405218","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10316047"},"language":"en","primary_location":{"id":"doi:10.21873/cdp.10241","doi":"https://doi.org/10.21873/cdp.10241","is_oa":true,"landing_page_url":"https://doi.org/10.21873/cdp.10241","pdf_url":"https://www.cancerdiagnosisprognosis.org/storage/cdp/3/4/cdp-3-468.pdf","source":{"id":"https://openalex.org/S4210192968","display_name":"Cancer Diagnosis & Prognosis","issn_l":"2732-7787","issn":["2732-7787"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Diagnosis &amp; Prognosis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.cancerdiagnosisprognosis.org/storage/cdp/3/4/cdp-3-468.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059278756","display_name":"Akifumi Kuwano","orcid":"https://orcid.org/0000-0001-9397-8056","observed_orcids":["https://orcid.org/0000-0001-9397-8056"]},"institutions":[{"id":"https://openalex.org/I4210144416","display_name":"Aso Iizuka Hospital","ror":"https://ror.org/04tg98e93","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210144416"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"AKIFUMI KUWANO","raw_affiliation_strings":["Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan","institution_ids":["https://openalex.org/I4210144416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051642588","display_name":"Masayoshi Yada","orcid":"https://orcid.org/0000-0002-1129-5380","observed_orcids":["https://orcid.org/0000-0002-1129-5380"]},"institutions":[{"id":"https://openalex.org/I4210144416","display_name":"Aso Iizuka Hospital","ror":"https://ror.org/04tg98e93","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210144416"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"MASAYOSHI YADA","raw_affiliation_strings":["Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan","institution_ids":["https://openalex.org/I4210144416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005018426","display_name":"Yoshiko Miyazaki","orcid":"https://orcid.org/0000-0002-1938-1697","observed_orcids":["https://orcid.org/0000-0002-1938-1697"]},"institutions":[{"id":"https://openalex.org/I4210144416","display_name":"Aso Iizuka Hospital","ror":"https://ror.org/04tg98e93","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210144416"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"YOSHIKO MIYAZAKI","raw_affiliation_strings":["Department of Diagnostic Pathology, Aso Iizuka Hospital, Iizuka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diagnostic Pathology, Aso Iizuka Hospital, Iizuka, Japan","institution_ids":["https://openalex.org/I4210144416"]}]},{"author_position":"middle","author":{"id":null,"display_name":"KOSUKE TANAKA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144416","display_name":"Aso Iizuka Hospital","ror":"https://ror.org/04tg98e93","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210144416"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"KOSUKE TANAKA","raw_affiliation_strings":["Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan","institution_ids":["https://openalex.org/I4210144416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114063657","display_name":"YUTA KOGA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144416","display_name":"Aso Iizuka Hospital","ror":"https://ror.org/04tg98e93","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210144416"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"YUTA KOGA","raw_affiliation_strings":["Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan","institution_ids":["https://openalex.org/I4210144416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064266159","display_name":"Yoshihiro Ohishi","orcid":"https://orcid.org/0000-0001-5675-1944","observed_orcids":["https://orcid.org/0000-0001-5675-1944"]},"institutions":[{"id":"https://openalex.org/I4210144416","display_name":"Aso Iizuka Hospital","ror":"https://ror.org/04tg98e93","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210144416"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"YOSHIHIRO OHISHI","raw_affiliation_strings":["Department of Diagnostic Pathology, Aso Iizuka Hospital, Iizuka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diagnostic Pathology, Aso Iizuka Hospital, Iizuka, Japan","institution_ids":["https://openalex.org/I4210144416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112212701","display_name":"Akihide Masumoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144416","display_name":"Aso Iizuka Hospital","ror":"https://ror.org/04tg98e93","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210144416"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"AKIHIDE MASUMOTO","raw_affiliation_strings":["Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan","institution_ids":["https://openalex.org/I4210144416"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009242828","display_name":"Kenta Motomura","orcid":"https://orcid.org/0000-0002-7515-099X","observed_orcids":["https://orcid.org/0000-0002-7515-099X"]},"institutions":[{"id":"https://openalex.org/I4210144416","display_name":"Aso Iizuka Hospital","ror":"https://ror.org/04tg98e93","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210144416"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"KENTA MOTOMURA","raw_affiliation_strings":["Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan","institution_ids":["https://openalex.org/I4210144416"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210144416"],"apc_list":null,"apc_paid":null,"fwci":1.33,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.79434734,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"3","issue":"4","first_page":"468","last_page":"474"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12422","display_name":"Radiomics and Machine Learning in Medical Imaging","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.8920000195503235},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9670000076293945},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8700000047683716},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.7139999866485596},{"id":"https://openalex.org/keywords/cd8-tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating CD8+ T cells","score":0.8880000114440918},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.871999979019165},{"id":"https://openalex.org/keywords/ct-imaging-features","display_name":"CT imaging features","score":0.5360000133514404},{"id":"https://openalex.org/keywords/mri-imaging-features","display_name":"MRI imaging features","score":0.8130000233650208},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.3840000033378601}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.9628429412841797},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7815418243408203},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7437329292297363},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6333821415901184},{"id":"https://openalex.org/C2776401178","wikidata":"https://www.wikidata.org/wiki/Q12050496","display_name":"Feature (linguistics)","level":2,"score":0.48933833837509155},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.4526006579399109},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.450607031583786},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44598662853240967},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.418666273355484},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23081764578819275},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12377533316612244},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.06802502274513245},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.05303969979286194},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.21873/cdp.10241","doi":"https://doi.org/10.21873/cdp.10241","is_oa":true,"landing_page_url":"https://doi.org/10.21873/cdp.10241","pdf_url":"https://www.cancerdiagnosisprognosis.org/storage/cdp/3/4/cdp-3-468.pdf","source":{"id":"https://openalex.org/S4210192968","display_name":"Cancer Diagnosis & Prognosis","issn_l":"2732-7787","issn":["2732-7787"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Diagnosis &amp; Prognosis","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10316047","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10316047","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10316047/pdf/cdp-3-468.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Diagn Progn","raw_type":"Text"},{"id":"pmid:37405218","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37405218","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer diagnosis & prognosis","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.21873/cdp.10241","doi":"https://doi.org/10.21873/cdp.10241","is_oa":true,"landing_page_url":"https://doi.org/10.21873/cdp.10241","pdf_url":"https://www.cancerdiagnosisprognosis.org/storage/cdp/3/4/cdp-3-468.pdf","source":{"id":"https://openalex.org/S4210192968","display_name":"Cancer Diagnosis & Prognosis","issn_l":"2732-7787","issn":["2732-7787"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Diagnosis &amp; Prognosis","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4382986119.pdf","grobid_xml":"https://content.openalex.org/works/W4382986119.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1997621788","https://openalex.org/W2036394799","https://openalex.org/W2039994523","https://openalex.org/W2079586464","https://openalex.org/W2096998441","https://openalex.org/W2103310685","https://openalex.org/W2110741982","https://openalex.org/W2119190881","https://openalex.org/W2125816991","https://openalex.org/W2130325374","https://openalex.org/W2135774165","https://openalex.org/W2164272987","https://openalex.org/W2231373247","https://openalex.org/W2606367731","https://openalex.org/W2727290422","https://openalex.org/W2787358630","https://openalex.org/W2802511149","https://openalex.org/W2805592007","https://openalex.org/W2809507391","https://openalex.org/W2809624348","https://openalex.org/W2885326465","https://openalex.org/W2899174828","https://openalex.org/W2903051249","https://openalex.org/W2911120667","https://openalex.org/W2915597952","https://openalex.org/W2917616870","https://openalex.org/W2921899076","https://openalex.org/W3025022288","https://openalex.org/W3044786201","https://openalex.org/W3090240121","https://openalex.org/W3124556679","https://openalex.org/W3128646645","https://openalex.org/W3153073605","https://openalex.org/W3201700496","https://openalex.org/W3211603851","https://openalex.org/W4283325186","https://openalex.org/W4318990157","https://openalex.org/W4367313153"],"related_works":["https://openalex.org/W4396702424","https://openalex.org/W4405171465","https://openalex.org/W4410815442","https://openalex.org/W4412028736","https://openalex.org/W4378528427","https://openalex.org/W4410795511","https://openalex.org/W7118194470","https://openalex.org/W4391309804","https://openalex.org/W4403057682","https://openalex.org/W4292756365"],"abstract_inverted_index":{"BACKGROUND/AIM:":[0],"Systemic":[1],"chemotherapy":[2,83],"with":[3,25,99,113,127,136,149],"atezolizumab":[4,45,91,176],"plus":[5,46,92,177],"bevacizumab":[6,47],"is":[7,15],"approved":[8],"for":[9,22,48,172],"unresectable":[10],"hepatocellular":[11],"carcinoma":[12],"(HCC).":[13],"It":[14],"necessary":[16],"to":[17,33,82,175],"identify":[18],"probable":[19],"predictive":[20],"biomarkers":[21],"chemotherapies.":[23],"HCC":[24,49,64,148],"rim":[26,77,100,107,114,123,128,139,150],"arterial-phase":[27],"enhancement":[28],"(APHE)":[29],"has":[30],"been":[31],"linked":[32],"aggressive":[34],"tumor":[35,144],"activity.":[36],"PATIENTS":[37],"AND":[38],"METHODS:":[39],"We":[40,109],"studied":[41],"the":[42,74],"efficacy":[43],"of":[44,76,156],"using":[50],"computed":[51],"tomography":[52],"(CT)":[53],"or":[54,69],"magnetic":[55],"resonance":[56],"imaging":[57,59,166],"(MRI)":[58],"features.":[60],"In":[61],"total,":[62],"51":[63],"patients":[65,98,105,112,126],"who":[66,89],"underwent":[67],"CT":[68],"MRI":[70],"were":[71,84,95],"classified":[72],"by":[73],"feature":[75],"APHE.":[78,108],"RESULTS:":[79],"Clinical":[80],"responses":[81],"evaluated,":[85],"and":[86,102,125],"among":[87],"those":[88,121,137],"received":[90],"bevacizumab,":[93],"there":[94],"10":[96],"(19.6%)":[97],"APHE":[101,115,129,140,151,163],"41":[103],"(80.4%)":[104],"without":[106,122,138],"found":[110],"that":[111,147],"had":[116,130,152],"a":[117,153,169],"better":[118],"response":[119,174],"than":[120],"APHE,":[124],"longer":[131],"median":[132],"progression-free":[133],"survival":[134],"compared":[135],"(p=0.026).":[141],"Furthermore,":[142],"liver":[143],"biopsy":[145],"showed":[146],"higher":[154],"proportion":[155],"CD8+":[157],"tumor-infiltrating":[158],"lymphocytes":[159],"(p<0.01).":[160],"CONCLUSION:":[161],"Rim":[162],"in":[164],"CT/MRI":[165],"might":[167],"be":[168],"noninvasive":[170],"biomarker":[171],"predicting":[173],"bevacizumab.":[178]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-07-04T00:00:00"}